Phase I Study to Evaluate the Safety of Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen Specific T Cell Clones Targeting Cancer Testis Antigens for Patients With Metastatic Melanoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccine; Interleukin-2
- Indications Malignant melanoma
- Focus Adverse reactions
- 11 May 2010 Actual end date (Jun 2005) added as reported by ClinicalTrials.gov.
- 11 May 2010 Actual end date (Jun 2005) added as reported by ClinicalTrials.gov.
- 11 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.